Page last updated: 2024-10-30

mesalamine and Body Weight

mesalamine has been researched along with Body Weight in 16 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
" The ameliorating effect of the azo conjugate and therapeutic efficacy of the carrier system was evaluated in trinitrobenzenesulfonic acid-induced experimental colitis model."7.74Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats. ( Bhatt, L; Dhaneshwar, SS; Gairola, N; Kandpal, M; Vadnerkar, G, 2007)
" The ameliorating effect of the azo conjugate and therapeutic efficacy of the carrier system was evaluated in trinitrobenzenesulfonic acid-induced experimental colitis model."3.74Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats. ( Bhatt, L; Dhaneshwar, SS; Gairola, N; Kandpal, M; Vadnerkar, G, 2007)
" Dissolution studies of the prepared formulation conducted in simulated colonic fluid clearly demonstrated its superiority over the marketed, delayed release dosage forms of mesalamine."1.46Role of synbiotics in polysaccharide assisted colon targeted microspheres of mesalamine for the treatment of ulcerative colitis. ( Gulati, M; Kaur, R; Singh, SK, 2017)
"The risk of colorectal cancer is increased in patients with inflammatory bowel diseases, especially those with ulcerative colitis (UC)."1.345-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model. ( Endo, H; Fujisawa, T; Fujita, K; Ikeda, I; Inamori, M; Kubota, K; Nagashima, Y; Nakagama, H; Nakajima, A; Nozaki, Y; Saito, S; Takahashi, H; Tomimoto, A; Wada, K; Yoneda, M; Yonemitsu, K, 2007)

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (12.50)18.2507
2000's8 (50.00)29.6817
2010's4 (25.00)24.3611
2020's2 (12.50)2.80

Authors

AuthorsStudies
Dhaneshwar, SS1
Gairola, N1
Kandpal, M1
Vadnerkar, G1
Bhatt, L1
Su, XL1
Zhang, T1
Guo, S1
Wang, X2
Chen, L1
Wei, W1
Huang, S1
Xie, X1
Su, Y1
Pan, Z1
Li, Y1
Liang, J1
Zhang, M1
Pan, S1
Xu, B1
Li, L1
Chen, J1
Luo, X1
Zhou, L1
Mohanta, S1
Singh, SK2
Kumar, B1
Gulati, M2
Kumar, R1
Yadav, AK1
Wadhwa, S1
Jyoti, J1
Som, S1
Dua, K1
Pandey, NK1
Choi, KC1
Cho, SW1
Kook, SH1
Chun, SR1
Bhattarai, G1
Poudel, SB1
Kim, MK1
Lee, KY1
Lee, JC1
Balaha, M1
Kandeel, S1
Elwan, W1
Kaur, R1
Diamanti, A1
Basso, MS1
Gambarara, M1
Papadatou, B1
Bracci, F1
Noto, C1
Castro, M1
Chen, Y2
Liu, WL1
Zhou, TH1
Cai, JT1
Du, Q1
Wang, LJ1
Wu, JG1
Si, JM1
Mesker, T1
van Rheenen, PF1
Norbruis, OF1
Uitentuis, J1
Waalkens, HJ1
Gonera, G1
van Overbeek, LA1
Butler, J1
Rings, EH1
Jaiswal, A1
Parihar, VK1
Sudheer Kumar, M1
Manjula, SD1
Krishnanand, BR1
Shanbhag, R1
Unnikrishnan, MK1
Mladenovska, K1
Raicki, RS1
Janevik, EI1
Ristoski, T1
Pavlova, MJ1
Kavrakovski, Z1
Dodov, MG1
Goracinova, K1
Ikeda, I1
Tomimoto, A1
Wada, K1
Fujisawa, T1
Fujita, K1
Yonemitsu, K1
Nozaki, Y1
Endo, H1
Takahashi, H1
Yoneda, M1
Inamori, M1
Kubota, K1
Saito, S1
Nagashima, Y1
Nakagama, H1
Nakajima, A1
Kitano, A1
Matsumoto, T1
Oshitani, N1
Nakagawa, M1
Yasuda, K1
Watanabe, Y1
Tomobuchi, M1
Obayashi, M1
Tabata, A1
Fukushima, R1
Okabe, H1
Nakamura, S1
Obata, A1
Okawa, K1
Kobayashi, K2
Hirouchi, Y1
Kakamu, S1
Shoji, A1
Enomoto, M1
Hatakeyama, S1
Yonezawa, K1
Hedin, A1
Ehrsson, H1
Eksborg, S1
Finkel, Y1
Hildebrand, H1
Lidehäll, AK1

Other Studies

16 other studies available for mesalamine and Body Weight

ArticleYear
Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats.
    Bioorganic & medicinal chemistry, 2007, Jul-15, Volume: 15, Issue:14

    Topics: Animals; Azo Compounds; Body Weight; Colitis; Kinetics; Mesalamine; Molecular Structure; Organ Size;

2007
Efficacy of Wumei Baijiang prescription on regulatory T cells / helper T cells Immune balance in mice with ulcerative coliti.
    Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2022, Volume: 42, Issue:1

    Topics: Animals; Body Weight; Colitis, Ulcerative; Colon; Disease Models, Animal; Drugs, Chinese Herbal; Int

2022
Dahuang Mudan decoction repairs intestinal barrier in chronic colitic mice by regulating the function of ILC3.
    Journal of ethnopharmacology, 2022, Dec-05, Volume: 299

    Topics: Animals; Body Weight; Caco-2 Cells; Claudin-1; Colitis; Colitis, Ulcerative; Culture Media, Conditio

2022
Efficacy of co-administration of modified apple polysaccharide and probiotics in guar gum-Eudragit S100 based mesalamine mini tablets: A novel approach in treating ulcerative colitis.
    International journal of biological macromolecules, 2019, Apr-01, Volume: 126

    Topics: Animals; Body Weight; Colitis, Ulcerative; Colon; Drug Liberation; Galactans; Malus; Mannans; Mesala

2019
Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.
    Journal of ethnopharmacology, 2016, Feb-17, Volume: 179

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Colitis, Ulcerative; Colon; Cytokines

2016
Garlic oil inhibits dextran sodium sulfate-induced ulcerative colitis in rats.
    Life sciences, 2016, Feb-01, Volume: 146

    Topics: Allyl Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants;

2016
Role of synbiotics in polysaccharide assisted colon targeted microspheres of mesalamine for the treatment of ulcerative colitis.
    International journal of biological macromolecules, 2017, Volume: 95

    Topics: Animals; Body Weight; Colitis, Ulcerative; Colon; Diarrhea; Drug Carriers; Drug Liberation; Feces; F

2017
Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.
    International journal of colorectal disease, 2009, Volume: 24, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Body Heig

2009
Therapeutic effects of rectal administration of muscovite on experimental colitis in rats.
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:5

    Topics: Administration, Rectal; Aluminum Silicates; Animals; Anti-Inflammatory Agents; Body Weight; Colitis;

2009
Pediatric Crohn's disease activity at diagnosis, its influence on pediatrician's prescribing behavior, and clinical outcome 5 years later.
    Inflammatory bowel diseases, 2009, Volume: 15, Issue:11

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Body Height; Body Weight

2009
5-Aminosalicylic acid reverses endosulfan-induced testicular toxicity in male rats.
    Mutation research, 2005, Aug-01, Volume: 585, Issue:1-2

    Topics: Animals; Antidotes; Body Weight; Cell Shape; Endosulfan; Insecticides; L-Lactate Dehydrogenase; Leyd

2005
Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
    International journal of pharmaceutics, 2007, Sep-05, Volume: 342, Issue:1-2

    Topics: Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; B-Lymphocytes; Body Weight; Calcium; Ca

2007
5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Nov-01, Volume: 13, Issue:21

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Colitis; Colitis, Ulcerative; Disease

2007
Distribution and anti-inflammatory effect of mesalazine on carrageenan-induced colitis in the rabbit.
    Clinical and experimental pharmacology & physiology, 1996, Volume: 23, Issue:4

    Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Carrageenan; Co

1996
[Effects of mesalazine on liver carcinogenesis in medium-term bioassay using rats].
    The Journal of toxicological sciences, 1998, Volume: 23 Suppl 3

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Carcinogenicity

1998
[A study of 5-ASA use among young patients with Crohn disease. Regular drug revision is of significance for all children with chronic disease].
    Lakartidningen, 2001, Oct-03, Volume: 98, Issue:40

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Child; Crohn Disease; Dose-Respons

2001